Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort study
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie
PubMed
40436616
PubMed Central
PMC12765233
DOI
10.1002/ejhf.3701
Knihovny.cz E-zdroje
- Klíčová slova
- Cardiogenic shock, Heart failure, Kidney function, Kidney injury, Non‐AMI CS,
- MeSH
- akutní poškození ledvin * etiologie epidemiologie patofyziologie mortalita MeSH
- hodnoty glomerulární filtrace fyziologie MeSH
- kardiogenní šok * komplikace mortalita patofyziologie etiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití trendy MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- srdeční selhání * komplikace mortalita patofyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
AIMS: Heart failure-related cardiogenic shock (HF-CS) accounts for about half of CS cases, with a paucity of data regarding the role of kidney injury in this subset. This study aims to evaluate patient characteristics and outcome associated with renal function in patients with HF-CS. METHODS AND RESULTS: In this multicentre, international, retrospective study, patients with HF-CS from 16 tertiary care centres in five countries were enrolled between 2010 and 2021. To investigate differences in clinical presentation, complications, and 30-day mortality, based on renal function, adjusted logistic and Cox regression models were fitted. Among 1010 HF-CS patients, the median age was 64 (interquartile range [IQR] 52-75) years, with 71.7% being male. Median baseline creatinine was 1.7 (IQR 1.2-2.5) mg/dl, corresponding to an estimated glomerular filtration rate (eGFR) of 41.0 (IQR 25.2-62.2) ml/min/1.73 m2. In patients with acute kidney injury (AKI), 30-day mortality increased with AKI stages (no AKI 41.7%, AKI stage 1 43.3%, AKI stage 2 50.0%, AKI stage 3 63.7%; adjusted hazard ratio [HR] for AKI stage 3 1.97, 95% confidence interval [CI] 1.56-2.48, p < 0.001). Similarly, severe renal dysfunction (eGFR ≤ median) was associated with a 21% higher 30-day mortality risk (61.0% vs. 40.1%; adjusted HR 1.48, 95% CI 1.20-1.84, p < 0.001). Sepsis and bleeding were associated with both AKI and renal dysfunction, even after adjustment. CONCLUSIONS: In HF-CS, kidney injury is associated with higher 30-day mortality, potentially mediated by bleeding and sepsis. These findings support the consideration of kidney function as a prognostic marker and call for the development and evaluation of kidney-restoring adjunct interventions in HF-CS.
Anesthesia and Intensive Care Fondazione Policlinico San Matteo Hospital IRCCS Pavia Italy
Cardio Center Humanitas Clinical and Research Center IRCCS Rozzano Italy
Cardiovascular Center Aalst OLV Hospital Aalst Belgium
Department of Cardiology IKEM Prague Czech Republic
Department of Cardiology Paracelsus Medical University Nürnberg Nürnberg Germany
Department of Clinical Surgical Diagnostic and Paediatric Sciences University of Pavia Pavia Italy
Department of Intensive Care Medicine University Medical Center Hamburg Eppendorf Hamburg Germany
Department of Internal Medicine 1 University Hospital Jena Jena Germany
Department of Internal Medicine 1 University Hospital Würzburg Würzburg Germany
Department of Medicine 1 University Hospital LMU Munich Munich Germany
Department of Perioperative Medicine St Bartholomew's Hospital London UK
German Center for Cardiovascular Research Partner site Hamburg Kiel Lübeck Hamburg Germany
IRCCS Fondazione Don Gnocchi ONLUS Santa Maria Nascente Milan Italy
Medizinische Klinik 2 Kliniken Nordoberpfalz AG Weiden Germany
University Heart Center Lübeck University Hospital Schleswig Holstein Lübeck Germany
Zobrazit více v PubMed
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, PubMed DOI
Naidu SS Baran DA Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: A review and incorporation of validation studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 2022. 79 933 946 10.1016/j.jacc.2022.01.018 PubMed DOI
Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, PubMed DOI
Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, PubMed DOI PMC
Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Sørensen A, PubMed DOI
Schrage B, Becher PM, Goßling A, Savarese G, Dabboura S, Yan I, PubMed DOI PMC
Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird‐Zars VM, et al. Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 2019;12(3):e005618. 10.1161/CIRCOUTCOMES.119.005618 PubMed DOI PMC
Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, PubMed DOI
Thiele H, Ohman EM, De Waha‐Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: An update 2019. Eur Heart J 2019;40:2671–2683. 10.1093/eurheartj/ehz363 PubMed DOI
Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez‐Montfort J, Mahr C, PubMed DOI PMC
Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, Sörensen NA, PubMed DOI
Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, PubMed DOI
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, PubMed DOI
Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, PubMed DOI
Ghionzoli N, Sciaccaluga C, Mandoli G, Vergaro G, Gentile F, D'Ascenzi F, PubMed DOI PMC
Rewa O, Bagshaw SM. Acute kidney injury – epidemiology, outcomes and economics. Nat Rev Nephrol 2014;10:193–207. 10.1038/nrneph.2013.282 PubMed DOI
Zhang J, Bottiglieri T, McCullough PA. The central role of endothelial dysfunction in cardiorenal syndrome. Cardiorenal Med 2017;7:104–117. 10.1159/000452283 PubMed DOI PMC
Damman K, Testani JM. The kidney in heart failure: An update. Eur Heart J 2015;36:1437–1444. 10.1093/eurheartj/ehv010 PubMed DOI PMC
Tarvasmäki T, Haapio M, Mebazaa A, Sionis A, Silva‐Cardoso J, Tolppanen H, PubMed DOI
Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, PubMed DOI
Pickering JW, Blunt IRH, Than MP. Acute kidney injury and mortality prognosis in acute coronary syndrome patients: A meta‐analysis. Nephrol Ther 2018;23:237–246. 10.1111/NEP.12984 PubMed DOI
Uzendu A, Kennedy K, Chertow G, Amin AP, Giri JS, Rymer JA, PubMed DOI PMC
Dalia T, Pothuru S, Chan WC, Mehta H, Goyal A, Farhoud H, PubMed DOI PMC
Sheikh O, Nguyen T, Bansal S, Prasad A. Acute kidney injury in cardiogenic shock: A comprehensive review. Catheter Cardiovasc Interv 2021;98:E91–E105. 10.1002/ccd.29141 PubMed DOI
Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, PubMed DOI PMC
Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv, 2019; 94(1): 29–37. 10.1002/ccd.28329 PubMed DOI
Kramer HJ, Jaar BG, Choi MJ, Palevsky PM, Vassalotti JA, Rocco MV. An endorsement of the removal of race from GFR estimation equations: A position statement from the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Kidney Dis 2022;80:691–696. 10.1053/j.ajkd.2022.08.004 PubMed DOI
Inker LA Eneanya ND Coresh J Tighiouart H Wang D Sang Y, PubMed DOI PMC
Zweck E, Thayer KL, Helgestad OKL, Kanwar M, Ayouty M, Garan AR, PubMed DOI PMC
Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez‐Montfort J, PubMed DOI
Beer BN, Jentzer JC, Weimann J, Dabboura S, Yan I, Sundermeyer J, PubMed DOI
Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, PubMed DOI
Padkins M, Breen T, Van Diepen S, Barsness G, Kashani K, Jentzer JC. Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity. Catheter Cardiovasc Interv 2021;98:330–340. 10.1002/ccd.29692 PubMed DOI
Fuernau G, Poenisch C, Eitel I, Denks D, de Waha S, Pöss J, PubMed DOI
Marenzi G, Assanelli E, Campodonico J, de Metrio M, Lauri G, Marana I, PubMed DOI
Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, PubMed DOI
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, PubMed DOI
Jentzer JC, Bihorac A, Brusca SB, del Rio‐Pertuz G, Kashani K, Kazory A, PubMed DOI PMC
Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, PubMed DOI
Patsalis N, Kreutz J, Chatzis G, Syntila S, Griewing S, Pirlet‐Grant C, PubMed DOI PMC
Lauridsen MD, Gammelager H, Schmidt M, Rasmussen TB, Shaw RE, Bøtker HE, PubMed DOI PMC
Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence‐based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007;3:138–153. 10.1038/ncpneph0421 PubMed DOI
Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, PubMed DOI PMC
Hanberg JS, Sury K, Perry Wilson F, Wilson FP, Brisco MA, Ahmad T, PubMed DOI PMC
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, PubMed DOI PMC
Roman‐Pognuz E, Elmer J, Rittenberger JC, Guyette FX, Berlot G, De Rosa S, PubMed DOI PMC